The cost-effectiveness of tailored, postal feedback on general practitioners' prescribing of pharmacotherapies for alcohol dependence. / Navarro, Hector Jose; Shakeshaft, Anthony; Doran, Christopher M.; Petrie, Dennis J.
In: Drug and Alcohol Dependence, Vol. 124, No. 3, 2012, p. 207-215.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The cost-effectiveness of tailored, postal feedback on general practitioners' prescribing of pharmacotherapies for alcohol dependence
A1 - Navarro,Hector Jose
A1 - Shakeshaft,Anthony
A1 - Doran,Christopher M.
A1 - Petrie,Dennis J.
AU - Navarro,Hector Jose
AU - Shakeshaft,Anthony
AU - Doran,Christopher M.
AU - Petrie,Dennis J.
PY - 2012
Y1 - 2012
N2 - Aims: The aims of this study were to conduct a randomised controlled trial to evaluate the cost-effectiveness of tailored, postal feedback on general practitioners' (GPs) prescribing of acamprosate and naltrexone for alcohol dependence relative to current practice and its impact on alcohol dependence morbidity. Methods: Rural communities in New South Wales, Australia, were randomised into experimental (N= 10) and control (N= 10) communities. Tailored feedback on their prescribing of alcohol pharmacotherapies was mailed to GPs from the experimental communities (N= 115). Segmented regression analysis was used to examine within and between group changes in prescribing and alcohol dependence hospitalisation rates compared to the control communities. Incremental cost-effectiveness ratios (ICERs) were estimated per additional prescription of pharmacotherapies and per alcohol dependence hospitalisation(s) averted. Results: Post-intervention changes, relative to the control communities, in GPs' prescribing rate trends in the experimental communities significantly increased for acamprosate (ß= 0.24, 95% CI: 0.13-0.35, p
AB - Aims: The aims of this study were to conduct a randomised controlled trial to evaluate the cost-effectiveness of tailored, postal feedback on general practitioners' (GPs) prescribing of acamprosate and naltrexone for alcohol dependence relative to current practice and its impact on alcohol dependence morbidity. Methods: Rural communities in New South Wales, Australia, were randomised into experimental (N= 10) and control (N= 10) communities. Tailored feedback on their prescribing of alcohol pharmacotherapies was mailed to GPs from the experimental communities (N= 115). Segmented regression analysis was used to examine within and between group changes in prescribing and alcohol dependence hospitalisation rates compared to the control communities. Incremental cost-effectiveness ratios (ICERs) were estimated per additional prescription of pharmacotherapies and per alcohol dependence hospitalisation(s) averted. Results: Post-intervention changes, relative to the control communities, in GPs' prescribing rate trends in the experimental communities significantly increased for acamprosate (ß= 0.24, 95% CI: 0.13-0.35, p
UR - http://www.scopus.com/inward/record.url?partnerID=yv4JPVwI&eid=2-s2.0-84864010991&md5=16a9e53ff1f62ebfa3cdcd1dcf9f51d0
U2 - 10.1016/j.drugalcdep.2012.01.007
DO - 10.1016/j.drugalcdep.2012.01.007
M1 - Article
JO - Drug and Alcohol Dependence
JF - Drug and Alcohol Dependence
SN - 0376-8716
IS - 3
VL - 124
SP - 207
EP - 215
ER -